Trollguy retweeted
Breaking: Michael Burry says to “get out” of Nvidia $NVDA before it’s too late
Burry's reasonings:
1. Without Huang, customers are free to “slow down deals, push back, renegotiate terms, or simply walk to a competitor”
2. Nvidia financed customer purchases through special vehicles and hidden debt, creating “tremendous leverage in the system”
3. Huang pushed customers to buy chips they didn’t need yet by threatening to cut their future allocations
4. Its growth may slow and “critically, its margins may fall”
With Jensen Huang out, Burry says “Nvidia bulls will have another fluffy big chance to get out. Get out.”
Trollguy retweeted
We've derisked quite a bit. After derisking higher we kept re-adding. That has completely stopped.
This isn't purely an alpha based call. I don't have a good read on the market, we're up a lot into year end and want to crystallize gains, and I'm worried about what's coming.
Short term, crypto may be uninvestable. Democrats are probably going Gensler 2.0. There are plenty of nasty outcomes:
- DATs made illegal and forced to unwind
-Warren Banking Oversight
- Protocols pushing memecoins getting prosecuted
- Privacy tokens treated as hostile
Mid to long term, this is obviously a net good for Bitcoin. Democrats will likely accelerate spending and fiat debasement, and the industry may come out better once it gets "cleaned up."
Expect a tremendous amount of volatility. It will present incredible buying opportunities.
Note: The democrats cannot replace the CFTC chair who has been ruling favorably for stock perps and DeFi generally, so some assets may not be totally evisercated.
Trollguy retweeted
Zcash local top here because everyone on CT owns zcash and not a single one of them can explain why
It became a staple in everyones portfolio for no reason as it went up 30x in a year and everyone herded in
Now the whales are sitting on millions of uPnL while retail bought at $1000+ and no one conviction has yet to be tested
Classic crypto top
Trollguy retweeted
NVDA isn’t dropping because of the affair.
It’s dropping because new chip orders are about to fall off a cliff.
Rev will drop 80%.
Trollguy retweeted
This is disturbing.
Republican Congressman @RepThomasMassie just read his articles of impeachment for Pete Hegseth on the House floor.
Below he discusses the illegal strike that killed fleeing school children in Iran.
It's chilling to listen to.
Trollguy retweeted
This is why I waited to buy $USELESS until this retarded KOL kept bullposting it all the way from top to the bottom and once he sold, I went in heavy. And it did a 10x after that.
Same story for $ZCAT. Until this schmuck capitulates, holders will suffer.
Actual capitulation happening on $ZCAT right now
Never seen anything like this tbh
Of course it’s my coin
I’m cursed in crypto
Trollguy retweeted
$HIMS is trading at a $6B market cap.
2.6x sales for a company that is going to grow at an unprecedented rate.
The market is pricing it like growth is over. This is only the beginning.
Trollguy retweeted
You're not really awake yet until you realize The Titanic was purposefully sunk by (them) to get rid of all the powerful men who opposed the creation of the Federal Reserve system.
Trollguy retweeted
Good Lord, this is massive. It’s $HIMS × $LLY now.
Hims & Hers is turning into the most important distribution layer for Big Pharma, with Hims owning the customer relationship and building a wealth of patient data, while Big Pharma brings world-class medicines.
An extraordinary upgrade for the $HIMS thesis.
Congratulations to the long shareholders. We’ve had to put up with a lot of nonsense this year, but oh boy, was it worth it.
We’re working with @EliLillyandCo to expand access to Zepbound and Foundayo.
No more switching to third-party platforms, no more split payments. Just one, unified care experience that is simple, straightforward, and personal.
Read more, including important info: news.hims.com/newsroom/lilly…
Trollguy retweeted
$HIMS
$5 billion in revenue for 2027 is on the table
Market cap today: $6 billion
Trollguy retweeted
$HIMS just became a two-sided operating system for healthcare. Today, Eli Lilly signed a formal partnership to distribute Zepbound and Foundayo through the $HIMS platform. Earlier this year, Novo Nordisk did the same with Wegovy. The two companies that dominate obesity medicine now both supply through $HIMS.
This is the moment the flywheel grows a second side. Here's how it works:
1/ The supply side: pharma. Building a direct-to-consumer channel is slow, expensive and outside pharma's core skill. $HIMS already has the patients, the providers, the pharmacy logistics and the brand. Lilly plugs in and reaches millions of self-pay patients without building any of it. Lower cost to reach each patient means a higher return on every drug they've already spent billions developing.
2/ The demand side: patients. A patient opens one app and gets a consultation, a prescription if appropriate, and home delivery. Foundayo starts at $149/month and Zepbound at $299/month, branded and FDA-approved, with no compounded substitutes. More choice, lower friction, same price as anywhere else. Outcomes per dollar go up.
3/ The two sides feed each other. Every new pharma partner makes the platform more valuable to patients: wider catalog, better prices, more options for the provider to match to each person. Every new patient makes the platform more valuable to pharma: more reach, more demand, more real-world data on adherence and response.
4/ The data is where it compounds. Every consultation, every check-in, every lab panel, every switch from one therapy to another becomes longitudinal outcome data that no single drugmaker can collect on its own. Patients get treatment matched to them. Pharma learns what works, for whom, in the real world.
5/ This is why both sides improve outcomes per dollar at once. Pharma gets more outcome per R&D dollar because its drugs reach the right patients at a fraction of the distribution cost. Patients get more outcome per healthcare dollar because the platform matches them to the best intervention at the best price.
6/ Then the gravity flips. The more pharma supplies through $HIMS, the more patients come. The more patients come, the more pharma has to supply through $HIMS. Lilly and Novo are fierce competitors, and both just chose the same platform. That's what a two-sided network looks like in its early innings.
7/ Now add the biomarker loop. Generic peptides arrive on the same rails. The dataset deepens. The AI gets better at designing the right intervention for each person. Eventually pharma isn't just selling through $HIMS. It's building for it.
Just as $PLTR became the operating system for enterprise decisions, $HIMS is becoming the operating system where medicine meets the patient.
The molecule becomes the output. The platform that matches it to each human becomes the asset.
Trollguy retweeted
When we return next week, we’ll get 218 signatures for Epstein Files Transparency Act II, which guarantees a vote.
Survivors will be able to get their own records, State Attorneys General can prosecute crimes, and we can take the DOJ to court for keeping critical files hidden.⚖️
Trollguy retweeted
BREAKING: Thomas Massie is preparing to re-open the Epstein Files probe after Democrats re-take the House.
This is going to be FUCKING EPIC.
Trollguy retweeted
Impeach Trump, release the Epstien files, end the Iran war and decouple from Israel.
Trollguy retweeted
Tucker Carlson says Donald Trump "chose Israel over the United States", but that his presidency inadvertently revealed the hidden power structures shaping American politics.
"We should be thankful for the main thing he did for us, which is to reveal the subterranean architecture of power."
"Trump... pulled back the curtain and suddenly we could see how the system actually works."
"And it's been horrifying."

























